WallStreetZenWallStreetZen

NASDAQ: ESPR
Esperion Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for ESPR

Based on 2 analysts offering 12 month price targets for Esperion Therapeutics Inc.
Min Forecast
$8.00+213.73%
Avg Forecast
$12.00+370.59%
Max Forecast
$16.00+527.45%

Should I buy or sell ESPR stock?

Based on 2 analysts offering ratings for Esperion Therapeutics Inc.
Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ESPR stock forecasts and price targets.

ESPR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-02-28
lockedlocked$00.00+00.00%2024-02-27

1 of 1

Forecast return on equity

Is ESPR forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
34.96%

Forecast return on assets

Is ESPR forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

ESPR revenue forecast

What is ESPR's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$229.3M+97.09%
Avg 2 year Forecast
$458.9M+294.43%
Avg 3 year Forecast
$1.0B+778.59%
ESPR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ESPR revenue growth forecast

How is ESPR forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
95.59%
Industry
8.57%
Market
10.79%
ESPR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ESPR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ESPR vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
ESPR$2.55$12.00+370.59%Buy
PETQ$17.37$26.67+53.52%Strong Buy
PAHC$13.39$16.00+19.49%Hold
ORGO$2.92$4.83+65.51%Strong Buy
HROW$10.95N/AN/A

Esperion Therapeutics Stock Forecast FAQ

Is Esperion Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: ESPR) stock is to Buy ESPR stock.

Out of 2 analysts, 0 (0%) are recommending ESPR as a Strong Buy, 2 (100%) are recommending ESPR as a Buy, 0 (0%) are recommending ESPR as a Hold, 0 (0%) are recommending ESPR as a Sell, and 0 (0%) are recommending ESPR as a Strong Sell.

If you're new to stock investing, here's how to buy Esperion Therapeutics stock.

What is ESPR's revenue growth forecast for 2024-2026?

(NASDAQ: ESPR) Esperion Therapeutics's forecast annual revenue growth rate of 95.59% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 8.57%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.79%.

Esperion Therapeutics's revenue in 2024 is $116,334,000.On average, 5 Wall Street analysts forecast ESPR's revenue for 2024 to be $42,429,254,308, with the lowest ESPR revenue forecast at $31,227,643,969, and the highest ESPR revenue forecast at $62,096,285,690. On average, 4 Wall Street analysts forecast ESPR's revenue for 2025 to be $84,912,358,953, with the lowest ESPR revenue forecast at $65,453,141,759, and the highest ESPR revenue forecast at $131,424,431,091.

In 2026, ESPR is forecast to generate $189,142,369,781 in revenue, with the lowest revenue forecast at $189,142,369,781 and the highest revenue forecast at $189,142,369,781.

What is ESPR's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: ESPR) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of N/A.

What is ESPR's Price Target?

According to 2 Wall Street analysts that have issued a 1 year ESPR price target, the average ESPR price target is $12.00, with the highest ESPR stock price forecast at $16.00 and the lowest ESPR stock price forecast at $8.00.

On average, Wall Street analysts predict that Esperion Therapeutics's share price could reach $12.00 by Feb 28, 2025. The average Esperion Therapeutics stock price prediction forecasts a potential upside of 370.59% from the current ESPR share price of $2.55.

What is ESPR's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: ESPR) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.